$UBI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in UNIVERSAL BIOSENSORS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in UNIVERSAL BIOSENSORS INC. Get notifications about new insider transactions in UNIVERSAL BIOSENSORS INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 06 2014 | UBI | UNIVERSAL BIOSENSO ... | Chambers Garry | Vice President, Ope ... | Buy | M | 0.22 | 288,168 | 63,397 | 2,340,717 | 2.1 M to 2.3 M (+14.04 %) |
Jan 06 2014 | UBI | UNIVERSAL BIOSENSO ... | Chambers Garry | Vice President, Ope ... | Grant | A | 0.00 | 2,040 | 0 | 2,052,549 | 2.1 M to 2.1 M (+0.10 %) |
Jan 06 2014 | UBI | UNIVERSAL BIOSENSO ... | Oates Adrian | VP, Quality & Regul ... | Option Exercise | A | 0.00 | 40,000 | 0 | 40,000 | |
Jan 06 2014 | UBI | UNIVERSAL BIOSENSO ... | Oates Adrian | VP, Quality & Regul ... | Grant | A | 0.00 | 2,040 | 0 | 5,293 | 3.3 K to 5.3 K (+62.71 %) |
Jan 06 2014 | UBI | UNIVERSAL BIOSENSO ... | Balak Salesh | Chief Financial Off ... | Option Exercise | A | 0.00 | 40,000 | 0 | 40,000 | |
Jan 06 2014 | UBI | UNIVERSAL BIOSENSO ... | Balak Salesh | Chief Financial Off ... | Grant | A | 0.00 | 2,040 | 0 | 72,514 | 70.5 K to 72.5 K (+2.89 %) |
Oct 09 2013 | UBI | UNIVERSAL BIOSENSO ... | Heinberg Marshall | Director | Buy | J | 0.00 | 20,000 | 0 | 20,000 | 0 to 20 K |
Oct 04 2013 | UBI | UNIVERSAL BIOSENSO ... | Hanley Denis | Director | Buy | J | 0.00 | 200,000 | 0 | 954,105 | 754.1 K to 954.1 K (+26.52 %) |
Oct 04 2013 | UBI | UNIVERSAL BIOSENSO ... | Hanley Denis | Director | Buy | J | 0.00 | 6,000 | 0 | 54,889 | 48.9 K to 54.9 K (+12.27 %) |
Oct 04 2013 | UBI | UNIVERSAL BIOSENSO ... | Hanley Denis | Director | Buy | J | 0.00 | 29,772 | 0 | 1,868,002 | 1.8 M to 1.9 M (+1.62 %) |
Oct 04 2013 | UBI | UNIVERSAL BIOSENSO ... | DENVER ANDREW | Director | Buy | J | 0.00 | 200,000 | 0 | 2,736,340 | 2.5 M to 2.7 M (+7.89 %) |
Oct 04 2013 | UBI | UNIVERSAL BIOSENSO ... | DENVER ANDREW | Director | Buy | J | 0.00 | 28,000 | 0 | 437,050 | 409.1 K to 437.1 K (+6.85 %) |
Jun 11 2013 | UBI | UNIVERSAL BIOSENSO ... | Hodges Alastair | Chief Scientist | Option Exercise | M | 0.22 | 384,224 | 84,529 | 384,224 | |
Jun 11 2013 | UBI | UNIVERSAL BIOSENSO ... | Hodges Alastair | Chief Scientist | Buy | M | 84,529.30 | 384,224 | 32,478,178,079 | 2,444,226 | 2.1 M to 2.4 M (+18.65 %) |
Jun 11 2013 | UBI | UNIVERSAL BIOSENSO ... | Chambers Garry | Vice President, Ope ... | Option Exercise | M | 0.22 | 288,168 | 63,397 | 288,168 | |
Jun 11 2013 | UBI | UNIVERSAL BIOSENSO ... | Chambers Garry | Vice President, Ope ... | Buy | M | 63,397.00 | 288,168 | 18,268,975,169 | 2,050,509 | 1.8 M to 2.1 M (+16.35 %) |
May 28 2013 | UBI | UNIVERSAL BIOSENSO ... | Wright Paul | Chief Executive Off ... | Option Exercise | A | 0.00 | 37,500 | 0 | 37,500 | |
May 28 2013 | UBI | UNIVERSAL BIOSENSO ... | Wright Paul | Chief Executive Off ... | Grant | A | 0.00 | 917 | 0 | 917 | 0 to 917 |
Feb 20 2013 | UBI | UNIVERSAL BIOSENSO ... | Oates Adrian | VP, Quality & Regul ... | Sell | S | 7,291.38 | 8,333 | 60,759,070 | 3,253 | 11.6 K to 3.3 K (-71.92 %) |
Jan 08 2013 | UBI | UNIVERSAL BIOSENSO ... | DENVER ANDREW | Director | Buy | P | 378,646.00 | 676,153 | 256,022,412,469 | 2,536,340 | 1.9 M to 2.5 M (+36.35 %) |
Jan 08 2013 | UBI | UNIVERSAL BIOSENSO ... | DENVER ANDREW | Director | Sell | S | 378,646.00 | 676,153 | 256,022,412,469 | 60,797 | 737 K to 60.8 K (-91.75 %) |
Jan 08 2013 | UBI | UNIVERSAL BIOSENSO ... | DENVER ANDREW | Director | Buy | P | 379,890.00 | 678,375 | 257,707,878,750 | 1,860,187 | 1.2 M to 1.9 M (+57.40 %) |
Jan 08 2013 | UBI | UNIVERSAL BIOSENSO ... | DENVER ANDREW | Director | Sell | S | 379,890.00 | 678,375 | 257,707,878,750 | 409,050 | 1.1 M to 409.1 K (-62.38 %) |
Dec 28 2012 | UBI | UNIVERSAL BIOSENSO ... | Wright Paul | Chief Executive Off ... | Buy | J | 14,999.40 | 16,666 | 249,980,000 | 44,666 | 28 K to 44.7 K (+59.52 %) |
Dec 28 2012 | UBI | UNIVERSAL BIOSENSO ... | Balak Salesh | Chief Financial Off ... | Buy | J | 1,999.80 | 2,222 | 4,443,556 | 70,474 | 68.3 K to 70.5 K (+3.26 %) |
Dec 28 2012 | UBI | UNIVERSAL BIOSENSO ... | Wilson Elizabeth | Director | Buy | J | 3,999.60 | 4,444 | 17,774,222 | 2,035,944 | 2 M to 2 M (+0.22 %) |
Nov 23 2012 | UBI | UNIVERSAL BIOSENSO ... | Hodges Alastair | Chief Scientist | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
Nov 23 2012 | UBI | UNIVERSAL BIOSENSO ... | Hodges Alastair | Chief Scientist | Grant | A | 0.00 | 917 | 0 | 2,060,002 | 2.1 M to 2.1 M (+0.04 %) |
Nov 23 2012 | UBI | UNIVERSAL BIOSENSO ... | Oates Adrian | VP, Quality & Regul ... | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
Nov 23 2012 | UBI | UNIVERSAL BIOSENSO ... | Oates Adrian | VP, Quality & Regul ... | Grant | A | 0.00 | 917 | 0 | 11,586 | 10.7 K to 11.6 K (+8.59 %) |
Nov 23 2012 | UBI | UNIVERSAL BIOSENSO ... | Davis Frederick Harry | VP Business Develop ... | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
Nov 23 2012 | UBI | UNIVERSAL BIOSENSO ... | Davis Frederick Harry | VP Business Develop ... | Grant | A | 0.00 | 917 | 0 | 917 | 0 to 917 |
Nov 21 2012 | UBI | UNIVERSAL BIOSENSO ... | Chambers Garry | Vice President, Ope ... | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
Nov 21 2012 | UBI | UNIVERSAL BIOSENSO ... | Chambers Garry | Vice President, Ope ... | Grant | A | 0.00 | 917 | 0 | 1,762,341 | 1.8 M to 1.8 M (+0.05 %) |
Nov 21 2012 | UBI | UNIVERSAL BIOSENSO ... | Balak Salesh | Chief Financial Off ... | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
Nov 21 2012 | UBI | UNIVERSAL BIOSENSO ... | Balak Salesh | Chief Financial Off ... | Grant | A | 0.00 | 917 | 0 | 68,252 | 67.3 K to 68.3 K (+1.36 %) |
Aug 27 2012 | UBI | UNIVERSAL BIOSENSO ... | Davis Frederick Harry | VP Business Develop ... | Buy | P | 0.70 | 23,376 | 16,363 | 28,747 | 5.4 K to 28.7 K (+435.23 %) |
Aug 27 2012 | UBI | UNIVERSAL BIOSENSO ... | Davis Frederick Harry | VP Business Develop ... | Buy | P | 0.70 | 5,371 | 3,760 | 5,371 | 0 to 5.4 K |
Aug 27 2012 | UBI | UNIVERSAL BIOSENSO ... | Balak Salesh | Chief Financial Off ... | Option Exercise | M | 0.00 | 8,333 | 0 | 0 | |
Aug 27 2012 | UBI | UNIVERSAL BIOSENSO ... | Balak Salesh | Chief Financial Off ... | Option Exercise | M | 0.00 | 21,666 | 0 | 73,334 | |
Aug 27 2012 | UBI | UNIVERSAL BIOSENSO ... | Balak Salesh | Chief Financial Off ... | Option Exercise | M | 0.00 | 8,333 | 0 | 16,667 | |
Aug 27 2012 | UBI | UNIVERSAL BIOSENSO ... | Balak Salesh | Chief Financial Off ... | Buy | M | 0.00 | 38,332 | 0 | 67,335 | 29 K to 67.3 K (+132.17 %) |
Mar 06 2012 | UBI | UNIVERSAL BIOSENSO ... | Hodges Alastair | Chief Scientist | Sell | S | 0.73 | 1,000,000 | 730,000 | 2,059,085 | 3.1 M to 2.1 M (-32.69 %) |
Dec 07 2011 | UBI | UNIVERSAL BIOSENSO ... | Wright Paul | Chief Executive Off ... | Buy | P | 22,389.60 | 28,000 | 626,907,960 | 28,000 | 0 to 28 K |
Nov 28 2011 | UBI | UNIVERSAL BIOSENSO ... | Davis Frederick Harry | VP Business Develop ... | Option Exercise | A | 0.89 | 175,000 | 155,750 | 175,000 | |
Nov 23 2011 | UBI | UNIVERSAL BIOSENSO ... | Chambers Garry | Vice President, Ope ... | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
Nov 23 2011 | UBI | UNIVERSAL BIOSENSO ... | Chambers Garry | Vice President, Ope ... | Grant | A | 0.00 | 1,123 | 0 | 1,761,424 | 1.8 M to 1.8 M (+0.06 %) |
Nov 23 2011 | UBI | UNIVERSAL BIOSENSO ... | Balak Salesh | Chief Financial Off ... | Option Exercise | M | 0.00 | 8,333 | 0 | 8,333 | |
Nov 23 2011 | UBI | UNIVERSAL BIOSENSO ... | Balak Salesh | Chief Financial Off ... | Option Exercise | M | 0.00 | 10,000 | 0 | 95,000 | |
Nov 23 2011 | UBI | UNIVERSAL BIOSENSO ... | Balak Salesh | Chief Financial Off ... | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
Nov 23 2011 | UBI | UNIVERSAL BIOSENSO ... | Balak Salesh | Chief Financial Off ... | Grant | A | 0.00 | 1,123 | 0 | 29,003 | 27.9 K to 29 K (+4.03 %) |
Nov 23 2011 | UBI | UNIVERSAL BIOSENSO ... | Balak Salesh | Chief Financial Off ... | Buy | M | 0.00 | 18,333 | 0 | 27,880 | 9.5 K to 27.9 K (+192.03 %) |
Nov 23 2011 | UBI | UNIVERSAL BIOSENSO ... | Oates Adrian | VP., Quality & Regu ... | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
Nov 23 2011 | UBI | UNIVERSAL BIOSENSO ... | Oates Adrian | VP., Quality & Regu ... | Grant | A | 0.00 | 1,123 | 0 | 10,669 | 9.5 K to 10.7 K (+11.76 %) |
Nov 23 2011 | UBI | UNIVERSAL BIOSENSO ... | Hodges Alastair | Chief Scientist | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
Nov 23 2011 | UBI | UNIVERSAL BIOSENSO ... | Hodges Alastair | Chief Scientist | Grant | A | 0.00 | 1,123 | 0 | 3,059,085 | 3.1 M to 3.1 M (+0.04 %) |
Aug 08 2011 | UBI | UNIVERSAL BIOSENSO ... | DENVER ANDREW | Director | Buy | P | 2,100.00 | 2,000 | 4,200,000 | 736,950 | 735 K to 737 K (+0.27 %) |
Aug 08 2011 | UBI | UNIVERSAL BIOSENSO ... | DENVER ANDREW | Director | Buy | P | 2,190.00 | 2,000 | 4,380,000 | 734,950 | 733 K to 735 K (+0.27 %) |
Aug 08 2011 | UBI | UNIVERSAL BIOSENSO ... | DENVER ANDREW | Director | Buy | P | 864.00 | 720 | 622,080 | 732,950 | 732.2 K to 733 K (+0.10 %) |
Aug 08 2011 | UBI | UNIVERSAL BIOSENSO ... | DENVER ANDREW | Director | Buy | P | 327.60 | 280 | 91,728 | 732,230 | 732 K to 732.2 K (+0.04 %) |
May 13 2011 | UBI | UNIVERSAL BIOSENSO ... | Wright Paul | Chief Executive Off ... | Option Exercise | A | 1.38 | 2,300,000 | 3,174,000 | 2,300,000 | |
Nov 17 2010 | UBI | UNIVERSAL BIOSENSO ... | Oates Adrian | VP, Quality & Regul ... | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
Nov 17 2010 | UBI | UNIVERSAL BIOSENSO ... | Oates Adrian | VP, Quality & Regul ... | Grant | A | 1,000.00 | 632 | 632,000 | 9,546 | 8.9 K to 9.5 K (+7.09 %) |
Nov 17 2010 | UBI | UNIVERSAL BIOSENSO ... | Hodges Alastair | Chief Scientist | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
Nov 17 2010 | UBI | UNIVERSAL BIOSENSO ... | Hodges Alastair | Chief Scientist | Grant | A | 1,000.00 | 632 | 632,000 | 3,057,962 | 3.1 M to 3.1 M (+0.02 %) |
Nov 17 2010 | UBI | UNIVERSAL BIOSENSO ... | Chambers Garry | Vice President, Ope ... | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
Nov 17 2010 | UBI | UNIVERSAL BIOSENSO ... | Chambers Garry | Vice President, Ope ... | Grant | A | 1,000.00 | 632 | 632,000 | 1,760,301 | 1.8 M to 1.8 M (+0.04 %) |
Nov 17 2010 | UBI | UNIVERSAL BIOSENSO ... | Balak Salesh | Chief Financial Off ... | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
Nov 17 2010 | UBI | UNIVERSAL BIOSENSO ... | Balak Salesh | Chief Financial Off ... | Grant | A | 1,000.00 | 632 | 632,000 | 9,547 | 8.9 K to 9.5 K (+7.09 %) |
Aug 13 2010 | UBI | UNIVERSAL BIOSENSO ... | Hanley Denis | Director | Sell | S | 1,640,000.00 | 1,000,000 | 1,640,000,000,000 | 4,662,770 | 5.7 M to 4.7 M (-17.66 %) |
Aug 13 2010 | UBI | UNIVERSAL BIOSENSO ... | DENVER ANDREW | Director | Sell | S | 1,640,000.00 | 1,000,000 | 1,640,000,000,000 | 4,662,768 | 5.7 M to 4.7 M (-17.66 %) |
Aug 13 2010 | UBI | UNIVERSAL BIOSENSO ... | Adam Colin | Director | Sell | S | 1,640,000.00 | 1,000,000 | 1,640,000,000,000 | 4,662,768 | 5.7 M to 4.7 M (-17.66 %) |
May 27 2010 | UBI | UNIVERSAL BIOSENSO ... | Morrisson Mark | Managing Director/C ... | Option Exercise | M | 0.00 | 12,500 | 0 | 25,000 | |
May 27 2010 | UBI | UNIVERSAL BIOSENSO ... | Morrisson Mark | Managing Director/C ... | Buy | M | 0.00 | 12,500 | 0 | 13,081 | 581 to 13.1 K (+2,151.46 %) |
May 17 2010 | UBI | UNIVERSAL BIOSENSO ... | Morrisson Mark | Managing Director/C ... | Option Exercise | A | 0.00 | 37,500 | 0 | 37,500 | |
May 17 2010 | UBI | UNIVERSAL BIOSENSO ... | Morrisson Mark | Managing Director/C ... | Option Exercise | A | 0.00 | 142,500 | 0 | 142,500 | |
May 17 2010 | UBI | UNIVERSAL BIOSENSO ... | Morrisson Mark | Managing Director/C ... | Option Exercise | A | 1.72 | 150,000 | 258,000 | 150,000 | |
May 17 2010 | UBI | UNIVERSAL BIOSENSO ... | Morrisson Mark | Managing Director/C ... | Grant | A | 1,000.00 | 581 | 581,000 | 581 | 0 to 581 |
Apr 08 2010 | UBI | UNIVERSAL BIOSENSO ... | Wilson Elizabeth | Director | Buy | P | 3,188.50 | 1,800 | 5,739,300 | 2,046,500 | 2 M to 2 M (+0.09 %) |
Apr 08 2010 | UBI | UNIVERSAL BIOSENSO ... | Wilson Elizabeth | Director | Buy | P | 2,681,600.00 | 1,600,000 | 4,290,560,000,000 | 2,044,700 | 444.7 K to 2 M (+359.79 %) |
Apr 08 2010 | UBI | UNIVERSAL BIOSENSO ... | Wilson Elizabeth | Director | Sell | S | 2,681,600.00 | 1,600,000 | 4,290,560,000,000 | 0 | 1.6 M to 0 (-100.00 %) |
Feb 17 2010 | UBI | UNIVERSAL BIOSENSO ... | Oates Adrian | VP, Quality & Regul ... | Option Exercise | M | 0.00 | 8,333 | 0 | 16,667 | |
Feb 17 2010 | UBI | UNIVERSAL BIOSENSO ... | Oates Adrian | VP, Quality & Regul ... | Buy | M | 0.00 | 8,333 | 0 | 8,914 | 581 to 8.9 K (+1,434.25 %) |
Feb 17 2010 | UBI | UNIVERSAL BIOSENSO ... | Hodges Alastair | Chief Scientist | Option Exercise | M | 0.00 | 8,333 | 0 | 16,667 | |
Feb 17 2010 | UBI | UNIVERSAL BIOSENSO ... | Hodges Alastair | Chief Scientist | Buy | M | 0.00 | 8,333 | 0 | 3,057,330 | 3 M to 3.1 M (+0.27 %) |
Feb 17 2010 | UBI | UNIVERSAL BIOSENSO ... | Chambers Garry | Vice President, Ope ... | Option Exercise | M | 0.00 | 8,333 | 0 | 16,667 | |
Feb 17 2010 | UBI | UNIVERSAL BIOSENSO ... | Chambers Garry | Vice President, Ope ... | Buy | M | 0.00 | 8,333 | 0 | 1,759,669 | 1.8 M to 1.8 M (+0.48 %) |
Feb 17 2010 | UBI | UNIVERSAL BIOSENSO ... | Balak Salesh | Chief Financial Off ... | Option Exercise | M | 0.00 | 8,334 | 0 | 16,666 | |
Feb 17 2010 | UBI | UNIVERSAL BIOSENSO ... | Balak Salesh | Chief Financial Off ... | Buy | M | 0.00 | 8,334 | 0 | 8,915 | 581 to 8.9 K (+1,434.42 %) |
Dec 08 2009 | UBI | UNIVERSAL BIOSENSO ... | Hodges Alastair | Chief Scientist | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
Dec 08 2009 | UBI | UNIVERSAL BIOSENSO ... | Hodges Alastair | Chief Scientist | Option Exercise | A | 0.00 | 105,000 | 0 | 105,000 | |
Dec 08 2009 | UBI | UNIVERSAL BIOSENSO ... | Hodges Alastair | Chief Scientist | Option Exercise | A | 1.72 | 100,000 | 172,000 | 100,000 | |
Dec 08 2009 | UBI | UNIVERSAL BIOSENSO ... | Hodges Alastair | Chief Scientist | Grant | A | 1,000.00 | 581 | 581,000 | 3,048,997 | 3 M to 3 M (+0.02 %) |
Dec 08 2009 | UBI | UNIVERSAL BIOSENSO ... | Balak Salesh | Chief Financial Off ... | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
Dec 08 2009 | UBI | UNIVERSAL BIOSENSO ... | Balak Salesh | Chief Financial Off ... | Option Exercise | A | 0.00 | 105,000 | 0 | 105,000 | |
Dec 08 2009 | UBI | UNIVERSAL BIOSENSO ... | Balak Salesh | Chief Financial Off ... | Option Exercise | A | 1.72 | 100,000 | 172,000 | 100,000 | |
Dec 08 2009 | UBI | UNIVERSAL BIOSENSO ... | Balak Salesh | Chief Financial Off ... | Grant | A | 1,000.00 | 581 | 581,000 | 581 | 0 to 581 |
Dec 08 2009 | UBI | UNIVERSAL BIOSENSO ... | Chambers Garry | Vice President, Ope ... | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
Dec 08 2009 | UBI | UNIVERSAL BIOSENSO ... | Chambers Garry | Vice President, Ope ... | Option Exercise | A | 0.00 | 105,000 | 0 | 105,000 | |
Dec 08 2009 | UBI | UNIVERSAL BIOSENSO ... | Chambers Garry | Vice President, Ope ... | Option Exercise | A | 1.72 | 100,000 | 172,000 | 100,000 | |
Dec 08 2009 | UBI | UNIVERSAL BIOSENSO ... | Chambers Garry | Vice President, Ope ... | Grant | A | 1,000.00 | 581 | 581,000 | 1,751,336 | 1.8 M to 1.8 M (+0.03 %) |
Dec 08 2009 | UBI | UNIVERSAL BIOSENSO ... | Oates Adrian | VP, Quality & Regul ... | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
Dec 08 2009 | UBI | UNIVERSAL BIOSENSO ... | Oates Adrian | VP, Quality & Regul ... | Option Exercise | A | 0.00 | 105,000 | 0 | 105,000 | |
Dec 08 2009 | UBI | UNIVERSAL BIOSENSO ... | Oates Adrian | VP, Quality & Regul ... | Option Exercise | A | 1.72 | 100,000 | 172,000 | 100,000 | |
Dec 08 2009 | UBI | UNIVERSAL BIOSENSO ... | Oates Adrian | VP, Quality & Regul ... | Grant | A | 1,000.00 | 581 | 581,000 | 581 | 0 to 581 |
May 27 2009 | UBI | UNIVERSAL BIOSENSO ... | Wilson Elizabeth | Director | Buy | P | 299,000.00 | 260,000 | 77,740,000,000 | 444,700 | 184.7 K to 444.7 K (+140.77 %) |
May 27 2009 | UBI | UNIVERSAL BIOSENSO ... | Wilson Elizabeth | Director | Buy | P | 93,635.60 | 78,863 | 7,384,384,323 | 184,700 | 105.8 K to 184.7 K (+74.51 %) |
May 21 2009 | UBI | UNIVERSAL BIOSENSO ... | Wilson Elizabeth | Director | Buy | P | 48,238.00 | 44,500 | 2,146,591,000 | 105,837 | 61.3 K to 105.8 K (+72.55 %) |
May 21 2009 | UBI | UNIVERSAL BIOSENSO ... | Wilson Elizabeth | Director | Buy | P | 17,732.20 | 16,637 | 295,010,944 | 61,337 | 44.7 K to 61.3 K (+37.22 %) |
May 20 2009 | UBI | UNIVERSAL BIOSENSO ... | Wilson Elizabeth | Director | Buy | P | 53,000.00 | 50,000 | 2,650,000,000 | 1,600,000 | 1.6 M to 1.6 M (+3.23 %) |
May 19 2009 | UBI | UNIVERSAL BIOSENSO ... | Wilson Elizabeth | Director | Buy | P | 2,398.50 | 2,000 | 4,797,000 | 44,700 | 42.7 K to 44.7 K (+4.68 %) |
May 19 2009 | UBI | UNIVERSAL BIOSENSO ... | Wilson Elizabeth | Director | Buy | P | 85,326.30 | 83,064 | 7,087,541,291 | 1,550,000 | 1.5 M to 1.6 M (+5.66 %) |
May 19 2009 | UBI | UNIVERSAL BIOSENSO ... | Wilson Elizabeth | Director | Buy | P | 203,121.00 | 166,936 | 33,908,170,530 | 1,466,936 | 1.3 M to 1.5 M (+12.84 %) |
Mar 03 2009 | UBI | UNIVERSAL BIOSENSO ... | Wilson Elizabeth | Director | Buy | P | 4,588.85 | 9,365 | 42,974,580 | 1,300,000 | 1.3 M to 1.3 M (+0.73 %) |
Feb 26 2009 | UBI | UNIVERSAL BIOSENSO ... | Wilson Elizabeth | Director | Buy | P | 2,450.00 | 5,000 | 12,250,000 | 42,700 | 37.7 K to 42.7 K (+13.26 %) |
Feb 26 2009 | UBI | UNIVERSAL BIOSENSO ... | Wilson Elizabeth | Director | Buy | P | 3,430.00 | 7,000 | 24,010,000 | 37,700 | 30.7 K to 37.7 K (+22.80 %) |
Feb 26 2009 | UBI | UNIVERSAL BIOSENSO ... | Wilson Elizabeth | Director | Buy | P | 16,581.60 | 33,412 | 554,022,749 | 1,290,635 | 1.3 M to 1.3 M (+2.66 %) |
Feb 26 2009 | UBI | UNIVERSAL BIOSENSO ... | Wilson Elizabeth | Director | Buy | P | 17,500.00 | 35,000 | 612,500,000 | 1,257,223 | 1.2 M to 1.3 M (+2.86 %) |
Jun 16 2008 | UBI | UNIVERSAL BIOSENSO ... | Morrisson Mark | Managing Director/C ... | Option Exercise | A | 0.89 | 150,000 | 133,500 | 150,000 | |
Jun 20 2008 | UBI | UNIVERSAL BIOSENSO ... | DENVER ANDREW | Director | Buy | P | 4,250.00 | 5,000 | 21,250,000 | 7,000 | 2 K to 7 K (+250.00 %) |
Jun 20 2008 | UBI | UNIVERSAL BIOSENSO ... | DENVER ANDREW | Director | Buy | P | 1,720.00 | 2,000 | 3,440,000 | 2,000 | 0 to 2 K |
Jun 04 2008 | UBI | UNIVERSAL BIOSENSO ... | Kiefel Charles | Director | Buy | P | 35,685.00 | 37,182 | 1,326,840,414 | 97,000 | 59.8 K to 97 K (+62.16 %) |
Jun 04 2008 | UBI | UNIVERSAL BIOSENSO ... | Kiefel Charles | Director | Buy | P | 3,581.25 | 3,750 | 13,429,688 | 10,000 | 6.3 K to 10 K (+60.00 %) |
Jun 04 2008 | UBI | UNIVERSAL BIOSENSO ... | Kiefel Charles | Director | Buy | P | 5,937.50 | 6,250 | 37,109,375 | 6,250 | 0 to 6.3 K |
Jun 05 2008 | UBI | UNIVERSAL BIOSENSO ... | Kiefel Charles | Director | Buy | P | 11,320.70 | 1,200 | 13,584,816 | 109,000 | 107.8 K to 109 K (+1.11 %) |
Jun 02 2008 | UBI | UNIVERSAL BIOSENSO ... | Kiefel Charles | Director | Buy | P | 14,192.80 | 16,038 | 227,624,608 | 16,038 | 0 to 16 K |
Jun 02 2008 | UBI | UNIVERSAL BIOSENSO ... | Kiefel Charles | Director | Buy | P | 22,123.80 | 25,000 | 553,093,750 | 41,038 | 16 K to 41 K (+155.88 %) |
Jun 02 2008 | UBI | UNIVERSAL BIOSENSO ... | Kiefel Charles | Director | Buy | P | 16,619.40 | 18,780 | 312,111,581 | 59,818 | 41 K to 59.8 K (+45.76 %) |
May 20 2008 | UBI | UNIVERSAL BIOSENSO ... | Wilson Elizabeth | Director | Sell | S | 403.29 | 467 | 188,336 | 30,700 | 31.2 K to 30.7 K (-1.50 %) |
May 20 2008 | UBI | UNIVERSAL BIOSENSO ... | Wilson Elizabeth | Director | Buy | P | 870.00 | 1,000 | 870,000 | 31,167 | 30.2 K to 31.2 K (+3.31 %) |
May 14 2008 | UBI | UNIVERSAL BIOSENSO ... | Wilson Elizabeth | Director | Buy | P | 4,002.00 | 3,335 | 13,346,670 | 18,335 | 15 K to 18.3 K (+22.23 %) |
May 14 2008 | UBI | UNIVERSAL BIOSENSO ... | Wilson Elizabeth | Director | Buy | P | 266,668.00 | 222,223 | 59,259,674,075 | 1,222,223 | 1000 K to 1.2 M (+22.22 %) |
May 14 2008 | UBI | UNIVERSAL BIOSENSO ... | Oates Adrian | VP, Quality & Regul ... | Option Exercise | A | 1.20 | 400,000 | 480,000 | 400,000 | |
Apr 30 2008 | UBI | UNIVERSAL BIOSENSO ... | Jane Andrew | Director | Buy | P | 3,117,010.00 | 2,597,505 | 8,096,438,670,030 | 17,794,384 | 15.2 M to 17.8 M (+17.09 %) |
Apr 30 2008 | UBI | UNIVERSAL BIOSENSO ... | Hodges Alastair | Chief Scientist | Option Exercise | A | 0.89 | 100,000 | 89,000 | 100,000 | |
Apr 30 2008 | UBI | UNIVERSAL BIOSENSO ... | Hanley Denis | Director | Buy | P | 10,666.80 | 8,889 | 94,817,185 | 48,889 | 40 K to 48.9 K (+22.22 %) |
Apr 30 2008 | UBI | UNIVERSAL BIOSENSO ... | CM Capital Venture Trust No. 3 | 10% Owner | Buy | P | 3,117,010.00 | 2,597,505 | 8,096,438,670,030 | 17,794,384 | 15.2 M to 17.8 M (+17.09 %) |
Apr 30 2008 | UBI | UNIVERSAL BIOSENSO ... | Chambers Garry | Vice President, Ope ... | Option Exercise | A | 0.89 | 100,000 | 89,000 | 100,000 | |
Apr 18 2008 | UBI | UNIVERSAL BIOSENSO ... | Wilson Elizabeth | Director | Buy | P | 8,886.20 | 11,832 | 105,141,518 | 30,167 | 18.3 K to 30.2 K (+64.53 %) |
Apr 30 2008 | UBI | UNIVERSAL BIOSENSO ... | Balak Salesh | Chief Financial Off ... | Option Exercise | A | 0.89 | 100,000 | 89,000 | 100,000 |